Evidence map›Paper›PMID 42383450›Full record

ArticleACS infectious diseases2026

Coumarin-Mediated Inhibition of Diadenylate Cyclase Correlates with Impaired Biofilm Formation in

Edwin M Rojas, Abhishek Govindan, Parvathy Babu, Soniya Joseph, Hua Zhang, Yanting Zhu, Tyrese Boddie, Hui-Ting Lee, Hui Wu, Sadanandan E Velu

Abstract read
In one paragraph

Article in ACS infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Edwin M RojasDepartment of Chemistry, University of Alabama at Birmingham, Birmingham, Alabama 35294, United States.
Abhishek GovindanDepartment of Chemistry, University of Alabama at Birmingham, Birmingham, Alabama 35294, United States.
Parvathy BabuDepartment of Chemistry, University of Alabama at Birmingham, Birmingham, Alabama 35294, United States.
Soniya JosephDepartment of Chemistry, University of Alabama at Birmingham, Birmingham, Alabama 35294, United States.
Hua ZhangDepartment of Biomaterial and Biomedical Sciences, School of Dentistry, Oregon Health & Science University, Portland, Oregon 97239, United States.
Yanting ZhuDepartment of Biomaterial and Biomedical Sciences, School of Dentistry, Oregon Health & Science University, Portland, Oregon 97239, United States.
Tyrese BoddieDepartment of Chemistry, University of Alabama at Birmingham, Birmingham, Alabama 35294, United States.ORCID 0009-0008-7977-2295
Hui-Ting LeeDepartment of Chemistry, University of Alabama at Birmingham, Birmingham, Alabama 35294, United States.ORCID 0000-0002-2648-4053
Hui WuDepartment of Biomaterial and Biomedical Sciences, School of Dentistry, Oregon Health & Science University, Portland, Oregon 97239, United States.ORCID 0000-0003-1694-3954
Sadanandan E VeluDepartment of Chemistry, University of Alabama at Birmingham, Birmingham, Alabama 35294, United States.ORCID 0000-0002-0342-2378

Funding

SMALL MOLECULE INHIBITORS OF CARIOGENIC BIOFILMSR01DE022350 · NIDCR · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Christian Corey Melander, Hui Wu · 2012 to 2026
$4.3M
BACTERIAL SECOND MESSENGER MEDIATED VIRULENCE REGULATION IN STREPTOCOCCUS MUTANSR01DE028329 · NIDCR · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WU, HUI · 2019 to 2023
$1.7M
Microbial Biofilms as Regulators of Amphetamine Use DisordersR21DA059844 · NIDA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CARTER, ANGELA MICHELLE, VELU, SADANANDAN E. · 2024 to 2025
$408k
Hydrogel encapsulated biofilm inhibitors for dental caries prevention and treatmentR21DE028349 · NIDCR · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI VELU, SADANANDAN E. · 2019 to 2020
$396k
Streptococcus mutans diadenylate cyclase: A promising target for preventing dental cariesF30DE030334 · NIDCR · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ROJAS, EDWIN M · 2020 to 2024
$212k
NIDA NIH HHS R21 DA059844NIDCR NIH HHS F30 DE030334NIDCR NIH HHS R01 DE022350NIDCR NIH HHS R01 DE028329NIDCR NIH HHS R21 DE028349
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsBacterial ProteinsBiofilmsCoumarinsEnzyme InhibitorsPhosphorus-Oxygen LyasesStreptococcus mutansStructure-Activity RelationshipAnti-Bacterial AgentsBacterial ProteinscoumarinCoumarinsEnzyme InhibitorsPhosphorus-Oxygen Lyasesbiofilmc-di-AMPcoumarindiadenylate cyclaseinhibitorS. mutans

Identifiers

PMID42383450
PMCPMC13366584

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.